Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 17/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18554306 | 1.00 | CFD (0.47) | CFDHPGDCYP2C9SLC6A2SLC6A4 | |
| SCHEMBL18555480 | 0.89 | CFD (0.47) | CFDHPGDCYP2C9SLC6A2SLC6A4 | |
| SCHEMBL28928082 | 0.87 | CFD (0.47) | CFDCYP2C9SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL18554828 | 0.87 | CFD (0.60) | CFD | |
| SCHEMBL17024892 | 0.87 | CFD (0.60) | CFD | |
| SCHEMBL23885399 | 0.87 | CFD (0.47) | CFDCYP2C9SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL18554933 | 0.86 | CFD (0.53) | CFDHPGDCYP2C9SLC6A2SLC6A4 | |
| SCHEMBL18554936 | 0.86 | CFD (0.53) | CFDHPGDCYP2C9SLC6A2SLC6A4 | |
| SCHEMBL23885086 | 0.84 | CFD (0.45) | CFDCYP2C9SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL23885158 | 0.84 | CFD (0.48) | CFDSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017035411-A1 | ETHER COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | disclosed |